Andrew C. Nelson
Affiliations: | 2007 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Google:
"Andrew Nelson"Parents
Sign in to add mentor| Jeffrey T. Holt | grad student | 2007 | University of Colorado, Denver | |
| (Molecular regulation of the breast and ovarian tumor suppressors BRCA1 and BRCA2.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tarullo SE, He Y, Daughters C, et al. (2023) Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology |
| Geistlinger L, Oh S, Ramos M, et al. (2020) Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma. Cancer Research |
| Witschen PM, Chaffee TS, Brady NJ, et al. (2020) Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers. 12 |
| Nelson AC, Turbyville TJ, Dharmaiah S, et al. (2020) internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling. The Journal of Biological Chemistry |
| Tarullo SE, Hill RC, Hansen KC, et al. (2020) Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival. Oncogene |
| Daughters CE, Knutson TP, Forster C, et al. (2020) Abstract 2731: Receptor for Hyaluronan Mediated Motility (RHAMM) promotes breast cancer progression Tumor Biology |
| Toyama A, Siegel L, Nelson AC, et al. (2019) Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |
| Irey EA, Lassiter CM, Brady NJ, et al. (2019) JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proceedings of the National Academy of Sciences of the United States of America |
| Lou E, Turbyville T, Simanshu D, et al. (2019) A novel RAS internal tandem duplication involving the switch II domain disrupts GAP-binding and activates oncogenic signaling. Journal of Clinical Oncology. 37 |
| Chang Z, Bedell SM, Uppendahl LD, et al. (2019) Comprehensive single cell analysis of a patient’s primary, recurrent, and xenograft ovarian cancer Gynecologic Oncology. 153 |